Literature DB >> 17111423

Polymorphisms in the thymidylate synthase promoter and the DNA repair genes XRCC1 and XPD in a Brazilian population.

Renata Canalle1, Vanessa da Silva S Andrade, Carlos A Scrideli, Rosane G de Paula Queiroz, Luiz G Tone.   

Abstract

Polymorphisms in genes responsible for maintaining genomic integrity are potential modifiers of disease risk. Since considerable interindividual and interethnic variation in DNA repair capacity has been associated with polymorphic alleles, we evaluated the frequency of the 2R/3R variants in the TS promoter, Arg194Trp and Arg399Gln in the XRCC1 gene, and Asp312Asn and Lys751Gln in the XPD gene in 364 healthy individuals from a Brazilian population separated by ethnicity (European ancestry and African ancestry). The genotypes were determined by PCR (TS) or by PCR-RFLP (XRCC1 and XPD). The frequency of the TS 3R allele was 0.56 for whites and 0.51 for nonwhites. In the case of the XRCC1 MspI polymorphism, the allele frequencies were 0.09 for 194Trp in both nonwhites and whites and 0.27 and 0.28 for 399Gln in nonwhites and whites, respectively. For the XPD 312Asn allele, we found a frequency of 0.25 in white individuals, which was significantly different (P = 0.025) from that seen in nonwhites (0.15). Similarly, the 751Gln polymorphic allele of the XPD gene was significantly more frequent (P < 0.002) in whites (0.30) than in nonwhites (0.20). The genotype frequencies were within Hardy-Weinberg equilibrium. We concluded that the genotype and allele frequencies of XPD gene polymorphism differed between white and nonwhite Brazilians, and that the frequencies of the XPD 312Asn and XRCC1 399Gln alleles in this Brazilian population showed ethnic variability when compared with those observed in other populations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17111423     DOI: 10.1002/em.20269

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  6 in total

1.  XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.

Authors:  Yunpeng Qi; Lianhua Cui; Yang Song; Na Li
Journal:  Mol Biol Rep       Date:  2014-01-04       Impact factor: 2.316

2.  Sensitivity to cisplatin-induced mutations and elevated chromosomal aberrations in lymphocytes from sickle cell disease patients.

Authors:  Polyanna Miranda Alves; Paulo Roberto Juliano Martins; Francisca da Luz Dias; Rommel Mario Rodríguez Burbano; Maria de Lourdes Pires Bianchi; Lusânia Maria Greggi Antunes
Journal:  Clin Exp Med       Date:  2008-04-03       Impact factor: 3.984

3.  Polymorphism of thymidylate synthase gene associated with its protein expression in human colon cancer.

Authors:  Kai-Huan Yu; Wei-Xing Wang; You-Ming Ding; Hui Li; Ze-Sheng Wang
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

4.  XRCC1 gene polymorphisms in a population sample and in women with a family history of breast cancer from Rio de Janeiro (Brazil).

Authors:  Priscila Falagan-Lotsch; Marina S Rodrigues; Viviane Esteves; Roberto Vieira; Luis C Amendola; Dante Pagnoncelli; Júlio C Paixão; Claudia V De Moura Gallo
Journal:  Genet Mol Biol       Date:  2009-06-01       Impact factor: 1.771

5.  Effect of genetic polymorphisms involved in folate metabolism on the concentration of serum folate and plasma total homocysteine (p-tHcy) in healthy subjects after short-term folic acid supplementation: a randomized, double blind, crossover study.

Authors:  Rona Cabo; Sigrunn Hernes; Audun Slettan; Margaretha Haugen; Shu Ye; Rune Blomhoff; M Azam Mansoor
Journal:  Genes Nutr       Date:  2015-03-11       Impact factor: 5.523

6.  TP53 and XRCC1 polymorphisms and breast cancer prognosis: a case-case study.

Authors:  Marina Silva Rodrigues; Camila Almeida Machado; Dante Pagnoncelli; Elizabeth Avvad; Júlio César da Paixão; Claudia Vitoria de Moura Gallo
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.